
Angel Adegbesan
Reporter at Bloomberg News
Stocks reporter @business. Alum at @newmarkjschool and @yorkcollegecuny
Articles
-
2 weeks ago |
bloomberg.com | Angel Adegbesan
Hi, all, it’s Angel in New York, where I report on health-care stocks. One company has been the source of much drama in recent months. But before I explain …Through much of 2024, UnitedHealth Group was flying high. The largest US health insurer by membership had posted years of double-digit revenue growth. Its shares hit a record high in November.
-
2 weeks ago |
news.bloombergtax.com | Angel Adegbesan
XYour Choices Regarding Cookies and IdentifiersWe and our 150 third party partners use cookies and similar technologies ("Cookies") and hashed identifiers (e.g., a hashed version of your name, email address or phone number) to help us identify you on our site and third-party sites and to process certain information, such as your IP address and digital identifiers, to analyze site usage and provide you with relevant advertisements and content.
-
2 weeks ago |
bloomberg.com | Angel Adegbesan
(Bloomberg) -- When CFRA’s Paige Meyer slapped a “sell” rating on UnitedHealth Group Inc. in February, she was the lone analyst out of 30 tracked by Bloomberg with a negative view of the company. Meyer’s price target implying a 22% fall for the shares glared in a sea of optimistic forecasts, while her warnings on regulatory uncertainty and high medical expenses seemed almost alarmist.
-
2 weeks ago |
yahoo.com | Angel Adegbesan
(Bloomberg) -- When CFRA’s Paige Meyer slapped a “sell” rating on UnitedHealth Group Inc. in February, she was the lone analyst out of 30 tracked by Bloomberg with a negative view of the company. Most Read from BloombergAdvertisementAdvertisementMeyer’s price target implying a 22% fall for the shares glared in a sea of optimistic forecasts, while her warnings on regulatory uncertainty and high medical expenses seemed almost alarmist.
-
2 weeks ago |
advisorperspectives.com | Angel Adegbesan
When CFRA’s Paige Meyer slapped a “sell” rating on UnitedHealth Group Inc. in February, she was the lone analyst out of 30 tracked by Bloomberg with a negative view of the company. Meyer’s price target implying a 22% fall for the shares glared in a sea of optimistic forecasts, while her warnings on regulatory uncertainty and high medical expenses seemed almost alarmist.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 258
- Tweets
- 175
- DMs Open
- No

RT @Alicia_Diaz23: NEWS: The list of ~20 countries that the US is engaging in initial trade talks with includes major exporters that the US…

RT @srimtaylor: For my latest @business story, I dug into 450 pages of rider complaints sent to NJ Transit to illustrate a system plagued b…

RT @CristinNara: A flurry of deals at the start of the year sparked optimism for a biotech stock resurgence but a swing in sentiment at the…